Skip to main content

Not investment advice.Read full disclaimer

XTLB: XTL Biopharmaceuticals Ltd. Fundamental Analysis | finqOS

Healthcare · Biotechnology

52W Range

1thpctl

Volume

0.00×avg

Market Cap

5.28MUSD

P/E Ratio

-3.8TTM

Div Yield

-ann

Loading analysis data...

Continue with finqOS

Analyze XTL Biopharmaceuticals Ltd.'s fundamentals

175+ metrics with multi-year trends, CAGR calculations, and customizable analysis templates.

Start Free Trial→Sign In

14-day free trial · No credit card required

XTL Biopharmaceuticals Ltd.

XTLBNASDAQ Capital Market·USD·Closed

XTL Biopharmaceuticals Ltd.

XTLBNASDAQ·USD·Closed

$2.23

−1.33%

$2.23

−$0.03 (1.33%)

52W Range

1thpctl

Volume

0.00×avg

Mkt Cap

5.28MUSD

P/E

-3.8TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings